These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19920824)

  • 1. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
    Chen G; Tian X; Liu Z; Zhou S; Schmidt B; Henne-Bruns D; Bachem M; Kornmann M
    Br J Cancer; 2010 Jan; 102(1):188-95. PubMed ID: 19920824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
    Tian X; Chen G; Zhou S; Henne-Bruns D; Bachem M; Kornmann M
    Hepatogastroenterology; 2012; 59(117):1604-8. PubMed ID: 22683979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
    Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
    Chen G; Wang J; Liu Z; Kornmann M
    Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.
    Liu Z; Neiss N; Zhou S; Henne-Bruns D; Korc M; Bachem M; Kornmann M
    Cancer Res; 2007 Mar; 67(6):2712-9. PubMed ID: 17363592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
    Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
    Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
    Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A.
    Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH
    J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin acts as a molecular switch to determine SPARC function in pancreatic cancer.
    Munasinghe A; Malik K; Mohamedi F; Moaraf S; Kocher H; Jones L; Hill NJ
    Cancer Lett; 2020 May; 477():88-96. PubMed ID: 32113990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
    Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
    Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
    Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells.
    Santolla MF; Talia M; Maggiolini M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.